Grifols SA (GRFS) Earnings Date & Reports

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

GRFS is expected to report earnings to fall 28.37% to 16 cents per share on May 01

Q1'25

Est.

$0.16

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.04

Q2'24

Est.

$0.09

Q1'24

Missed

by $0.07

The last earnings report on February 26 showed earnings per share of 22 cents, beating the estimate of 20 cents. With 500.12K shares outstanding, the current market capitalization sits at 5.48B.

View a ticker or compare two or three

Compare

GRFS